showed a trendp = 0.050
10 nM dapagliflozin strongly reduced release-inhibition by 11 mM glucose to 29% of control (p = 0.016), and showed a trend towards an inhibitory effect on secretion at low glucose (51% of control, p = 0.050).
10 nM dapagliflozin strongly reduced release-inhibition by 11 mM glucose to 29% of control (p = 0.016), and showed a trend towards an inhibitory effect on secretion at low glucose (51% of control, p = 0.050).